LYRA
Lyra Therapeutics Inc.
$6.69
+$0.26(+4.13%)
18
Overall
--
Value
18
Tech
--
Quality
Market Cap
$10.56M
Volume
10.23K
52W Range
$3.81 - $37.50
Target Price
$11.50
EPS Estimates Overview
| Current Quarter | $-5.97 | Next Quarter | $-4.19 |
| Current Year | $-18.46 | Next Year | $-6.64 |
| QoQ Growth | +29.8% | YoY Growth | +64.0% |
| 3Y EPS CAGR | +79.6% | Target Price | $11.50 |
| Consensus | Buy | Upside | +72.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LYRA | $6.69 | +4.1% | 10.23K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |